Skip to main content
. 2016 Dec 9;11(12):e0165118. doi: 10.1371/journal.pone.0165118

Fig 1. Changes in frequency of immune cell populations during glioma progression.

Fig 1

The frequency of different immune subsets was evaluated in brain, blood and spleen during progression of intracranial GL261 gliomas over a three-week period. A) Flow cytometry analysis of CD11b+CD45+ myeloid cells and CD11b+Gr1+ (marker of myeloid derived suppressor cells). B) Flow cytometry analysis of CD4+CD25+Foxp3+ and C) CD8+ T and NK cell. Data is representative of two separate experiments. n = 3 mice/group ± SD.